Article
GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance
14 Jan 2019
Abstract excerpt
Genomic amplification of the androgen receptor (AR) is an established mechanism of antiandrogen resistance in prostate cancer. Here, we show that the magnitude of AR signaling output, independent of AR genomic alteration or expression level, also contributes to antiandrogen resistance, through upregulation of the coactivator GREB1. We demonstrate 100-fold heterogeneity in AR output within human prostate cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
